The clinical performance of fillers in soft tissue augmentation depends upon their physiochemical properties, anatomical areas injected, interaction with the recipient, and the skill and experience of the physician. Scientific measures of filler properties facilitate appropriate selection of treatments for optimal treatment outcomes, and inform adjustments to treatments that improve patient safety and aesthetic outcomes. The rheological properties of calcium hydroxylapatite (CaHA), elastic modulus (G') and viscosity, coupled with its capacity to offer both immediate results and continued stimulation of collagen type I deposition, support its distinction as an ideal treatment for the volume loss characteristic of aging. Furthermore, the comparatively higher G' of CaHA offers a physiochemical basis for the clinical performance observed by the authors, especially in regions such as the temple and chin, where the force exerted by CaHA against bone permits expansion of overlaying tissue, permitting it to behave as a liquid implant.
Soft tissue augmentation with fillers continues to grow in popularity as an option for aesthetic enhancement, mitigating the effects of facial aging. The ability of both hyaluronic acid (HA) and biostimulatory fillers to revolumize tissues, coupled with the minimally invasive nature and improved accessibility of these treatments, has led to increased interest among patients seeking facial rejuvenation. 1 The paradigm shift in combating facial aging from filling individual wrinkles to a 3-dimensional approach to volume restoration is accompanied by a need to understand the physiochemical characteristics underlying the ideal applications of individual treatment options. 2 Though the clinical performance of fillers in soft tissue augmentation depends upon the anatomical areas injected, interaction with the recipient, and skill and experience of the physician, 3, 4 As the number of available fillers has increased, there is a need to quantitate their properties and tie these measures to assessments of deliverability, performance, immunogenicity, applications, aesthetic effectiveness, and longevity. 5, 6 For example, deliverability is shaped by both the extrusion force as well as product viscosity, both of which are tied to the precision with which the filler may be placed. Furthermore, expectations of performance can be tied to physiochemical properties that contribute to lift, such as elastic modulus (G'). 4 Though a scientific rationale for differentiating hyaluronic acid products was first addressed in an article by Kablik et al in 2009, 7 comparisons have since expanded to include several HA fillers and calcium hydroxylapatite (CaHA). 2, 8 More recent work by Lorenc has built upon this foundation and expanded to include more than 30 separate measures that may be considered when selecting either HA or biostimulatory agents.
Calcium Hydroxylapatite (CaHA) Physiochemical Properties
In comparative discussions of fillers, the primary rheological properties considered are complex viscosity (η*) and G'. Complex viscosity is defined as the degree to which a substance is resistant to nonrecoverable deformation by tensile stress, or more informally, "thickness." Fillers with higher viscosity are more likely to remain solid and remain in place following injection. 9 G' is a measure of gel stiffness, or the ability of a filler to resist elastic, or recoverable, deformation. Fillers may be subject to a variety of forces, including those exerted by resident facial muscles. Fillers with a higher G' are more resistant to deformation and are best suited for revolumization and provision of structural support. 2, 9 CaHA has a higher G' and viscosity than other commercially available HA fillers (Figures 1-2) . 9, 10 Hydroxylapatite microspheres in carboxymethyl cellulose carrier gel (Radiesse [CaHA] ; Merz North America, Inc., Raleigh, NC) is FDA-approved for correction of moderate to severe facial wrinkles and folds as well as for correction of volume loss in the hands. In addition to the immediate volume provided by CaHA, a low-grade inflammatory process stimulates collagen synthesis in the extracellular space surrounding the microspheres (see the following section for more information). 11 FDA approval in 2009 of the practice of mixing of lidocaine with CaHA and the 2015 approval of CaHA with integral 0.3% lidocaine hydrochloride prompted a comparison of the G' and viscosity of CaHA with (+) and without lidocaine to assess whether the rheological properties of CaHA are maintained. 10, 12 This study not only reinforced earlier demonstrations that CaHA has higher η* and G' than HA fillers, 9 but also that these rheological properties are maintained in the CaHA (+) formulation (Figures 1-2) .
The comparatively higher G' and viscosity of CaHA can be tied to its observed aesthetic effectiveness in restoration of the aging face through providing support, lift, and volume to soft tissues. In a treatment landscape ever expanding with choices, these scientific measures support the use of CaHA for revolumization. The dramatic difference between CaHA in G' and viscosity when compared to HAs suggests that CaHA and HA fillers may be considered complementary rather than competitive to each other. 13 Indeed, further treatment of fine lines through effacement may be used to tailor treatment plans to suit the needs of the patient and the areas being addressed.
The process of tying rheological properties to clinical outcomes is multifaceted, and measures such as G' and viscosity are two of many properties that may be considered when making comparisons between fillers with dissimilar composition. 7,14 While provider's clinical experience and individual patient needs should certainly be considered, objective assessments must be made with characteristics based in science. While laboratory measures obtained entirely outside of the context of clinical practice (eg, measures such as "biological interaction," or those obtained through animal model work) may be useful for describing agent behavior, they are largely irrelevant for predicting clinical filler performance. Rather, it is the consideration of objective factors known to dictate filler performance along with clinical experience that ensures selection of the appropriate product for achieving the best possible cosmetic results. In addition to objective measures of CaHA, G' and viscosity, the clinical experience of the authors is that CaHA it especially well suited for revolumization of areas especially difficult to treat with HAs. For example, the ability of CaHA to lend tissue support in both the chin ( Figure 3 ) and temple are illustrative of its lifting capacity in areas that are comparatively difficult to treat. Of particular importance when injecting the temple is avoidance of resident vasculature. Best practices for how to best prevent and treat adverse events, such as blindness, are the subject of various review articles. 15, 16 One advantage of CaHA injection in the supraperiostial plane is that this plane is absent of vasculature.
A thorough understanding of physiochemical properties supports methodological modifications that improve patient safety and outcomes. For example, inadequate usage recommendations for poly-L lactic acid (PLLA) use upon its approval in Europe in 1999 were at the root of the suboptimal cosmetic benefit and high rates of adverse events associated with its early use. 17 Following the initiation of two five-year studies, adjustments to product dilution, time to hydration, and plane of injection substantially reduced the incidence of adverse events from 10% to between 0.15% and 1%. 18, 19 Because there is somewhat of a disconnect between the narrow usage guidelines provided by regulatory agencies and the actual applications and techniques carried out in clinical practice, it is especially important that physicians be aware of how physiochemical properties inform appropriate use of available agents. In the case of CaHA, its high G' and viscosity make it especially well suited to provide support and volume. A high G' and viscosity indicate a need for comparatively less material and indicate that the material will be well contained. 8 The high G' and viscosity of CaHA inform its ideal placement into the supraperiosteal plane, where these forces are focused entirely upon lifting and expanding all overlying tissues, 8 enabling CaHA to behave as a subperiosteally placed liquid implant, 20 axially expending the face.
CaHA Biostimulatory Properties
One characteristic of an ideal filler is the ability to remodel the extracellular matrix through stimulation of collagen production, a feature that contributes to the longevity and sustained lifting capacity of CaHA. 21 HA fillers have been shown to stimulate some collagen deposition, 22 but not to the same degree as the biostimulatory agents calcium hydroxylapatite (CaHA, Radiesse; Figure 4 ) and poly-L lactic acid (PLLA, Sculptra). 23 The fibroblastic response characteristic of Radiesse is shown in detail in Figure 4 . One week postinjection, fibroblasts (dark purple) begin to surround the hydroxyapatite crystal (light brown) as it exerts its biostimulatory effect (A). Three months postinjection, local tissue has infiltrated the dermal implant, and the gel carrier carboxymethyl cellulose has been absorbed (B). Six months following injection, microspheres vary in size as they are broken up by the fibrous connective tissue response and are completely surrounded by fibrous connective tissue (C). Degradation of the crystals at six months is responsible for the observed waning of response that resurges between three and six months as collagen builds. 11 At 24 months postinjection, the crystal is completely reabsorbed by macrophages (D). Though no direct comparison of the collagen stimulated by HA and CaHA has been done, a dramatic difference in collagen may be qualitatively appreciated when comparing published images of collagen following injection of cross-linked HA to those presented in this supplement. 22 This difference may be due to a comparatively greater response of the body to the irregularly shaped hydroxyapatite. Furthermore, work is currently in progress to directly compare levels of elastin-a connective tissue indicative of overall skin health and flexibility-production stimulated by these two agents.
In combination with its collagen-stimulating capacity, effects of CaHA are also immediately apparent, making it a valuable tool for revolumization and tissue support. Because CaHA does not rely entirely on the gradual deposition of collagen over time, its use need not be limited in patients with diminished capacity to generate collagen, for example, older patients. In addition to the collagen-stimulating properties of Radiesse, placement over bone may activate periosteal stem cells, further supporting persistent volumization through stimulation of ossification. 24 Figure 1 . Elastic modulus (G') of calcium hydroxylapatite (CaHA) in 3 formulations: CaHA alone, CaHA with integral lidocaine, and CaHA in mix kit** (Meland et al, 2016 10 ) and 5 commercially available hyaluronic acid (HA) dermal fillers (Sundaram et al, 2010 9 ). Data for Radiesse were derived at a later date than those data for HA fillers. 10 ) and 5 commercially available hyaluronic acid (HA) dermal fillers (Sundaram et al, 2010 9 ). Data for Radiesse were derived at a later date than those data for HA fillers.
DISCUSSION
Rheological properties of fillers have been shown to be predictive of tissue integration patterns and useful in guiding appropriate clinical applications of studied fillers. 2 The high G' and viscosity of CaHA are indicative of the significant support and volumization observed with this agent in clinical practice. Injection into the supraperiosteal plane focuses these forces upon composite soft tissue lifting, offering a scientific basis for the efficacy of CaHA in revolumization when placed over bone in the midface, chin, or temporal hollow. While more controlled studies are needed to directly compare agents and to dissect the relative contributions of each rheological property to filler performance, basic science may be used to better understand clinical observations and guide treatment selection by informing expectations of filler performance.
CONCLUSIONS
The physiochemical, rheological, and biostimulatory properties of fillers each contribute to clinical performance and can inform treatment selection. The CaHA rheological profile includes a higher complex viscosity (η*) and elastic modulus (G') than HA fillers, providing a scientific basis for the observed ability of CaHA to serve as a liquid implant and provide exceptional tissue support in facial revolumization.
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